ANTI-LIPOLYTIC STRATEGY FOR HIV LIPODYSTROPHY

HIV 脂肪营养不良的抗脂肪分解策略

• 批准号: 7374779
• 负责人: COLLEEN M HADIGAN
• 金额: $ 6.09万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7374779
• 关键词: ANTI; LIPOLYTIC; STRATEGY; HIV; LIPODYSTROPHY

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine the utility of chronic administration of acipimox for the treatment of hypertriglyceridemia in patients with HIV infection and lipodystrophy.

该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金，因此可以在其他 CRISP 条目中得到体现。列出的机构是中心的机构，不一定是研究者的机构。本研究的目的是确定长期服用阿昔莫司治疗 HIV 感染和脂肪营养不良患者的高甘油三酯血症的效用。